𝐍𝐞𝐰 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 Our latest article forecasts the #burden and #healthcarecosts of obesity in the US from 2023 to 2060. It also identifies strategic intervention windows for obesity treatments to maximise cost savings. Click the link to read the full article 👉 bit.ly/48TDwuR #HEOR #Healtheconomics

Our latest article examines 𝐈𝐜𝐨𝐝𝐞𝐜's cost-effectiveness compared to other long-acting insulins, including glargine, detemir, and degludec. Discover the authors' findings by clicking the link 👉 bit.ly/4higT5r #diabetes #bloodsugar #costeffectiveness #healtheconomics #HEOR

A new analysis in @jme-journal.bsky.social identifies a costly gap in heart health. A majority of Americans with hypercholesterolemia are on statins, but most don't hit their LDL-C targets. Getting to goal was associated with a 50% reduction in cardiovascular events. bit.ly/48xvWWf

🚨 Available now🚨 Our latest review provides an essential insight into how #patientreportedoutcomemeasures can be included in #costeffectiveness models that inform #healthtechnologyassessments of non-oncology treatments. Read it here 👉 www.tandfonline.com/doi/full/10....

🚨 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐞𝐝 𝐚𝐫𝐭𝐢𝐜𝐥𝐞 🚨 Discover how Audrey Petitjean et al. assessed the use of external evidence for overall survival estimation in #oncology single-technology appraisals by the National Institute for Health and Care Excellence. Click the link for the full article 👉 bit.ly/4glH9ey #NICE #HEOR

📢 𝑹𝒆𝒄𝒐𝒎𝒎𝒆𝒏𝒅𝒆𝒅 𝒓𝒆𝒂𝒅 Discover the impact of treatment failure for #migraine on lost earnings among #triptan non-responders in the general population of #Denmark. Click the link for the full article 👉 bit.ly/4piFVoy

🚨 𝐍𝐨𝐰 𝐨𝐧𝐥𝐢𝐧𝐞 🚨 Our latest article evaluates the budgetary impact of pathways using cT1 versus SoC (liver biopsy or VCTE) to assign suspected #MASH patients to #resmetirom. See the graphical abstract below for an overview of the study. Click the link for the full article 👉 bit.ly/4g3dLJQ

📢 𝑱𝒖𝒔𝒕 𝒑𝒖𝒃𝒍𝒊𝒔𝒉𝒆𝒅: Our latest article assesses the economic impact of #influenzavaccination across the #UAE and #Iraq. Click the link to access it in full 👇 bit.ly/3K2tz3u Congratulations to the authors—it was lovely to collaborate with you. #publichealth #costeffectiveness #HEOR

📢 𝐑𝐞𝐜𝐨𝐦𝐦𝐞𝐧𝐝𝐞𝐝 𝐫𝐞𝐚𝐝𝐢𝐧𝐠 " #Costeffectiveness of wastewater and environmental monitoring of #respiratorysyncytialvirus to guide universal infant immunoprophylaxis in #Canada" Click the link to access the article in full or read the plain language summary below 👉 bit.ly/45BQlb3 #HEOR #Healtheconomics

We're excited to announce that our website now features a dedicated multimedia section showcasing our #videoabstracts. Access this content here👉 bit.ly/4oJik05 We have also expanded the extenders we offer to include #audioabstracts, #podcasts, and #videoarticles. Get in touch to find out more.

📣Available now View our webinar which provides an essential insight into the #submission and #peerreview processes, such as best practices for what should be included in your manuscript. 👉 bit.ly/40XWFaa #publishing #AI

We are currently commissioning articles for an article collection titled "Health Economics in #Cancer Treatment and Care" If you're interested in submitting, get in touch 👉 [email protected] So far, four articles have been published in the collection — you can access them here.👉 bit.ly/4167G9h

🚨 𝐑𝐞𝐜𝐨𝐦𝐦𝐞𝐧𝐝𝐞𝐝 𝐫𝐞𝐚𝐝🚨 Discover the preference of patients and physicians for treatments of Hepatitis C infections in Japan in this article. Click the link for the full article 👉 bit.ly/46e4njD #patientpreference #physicianpreference #hepatitisC #HEOR

🚨𝐖𝐞 𝐧𝐞𝐞𝐝 𝐲𝐨𝐮𝐫 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬🚨 What will shape #pharmacoeconomics in 2026? Your expert opinion matters! Take our quick survey, share your perspective, and be in for a chance to win a $40 Amazon gift voucher. Click here for the survey 👉 bit.ly/3ZAiPP8 #HEOR #healtheconomics #medicaleconomics

📢 Your expert opinion on #pharmacoeconomics trends for 2026 matters! Complete our short survey to share your views, and be in for a chance to win a $40 Amazon gift voucher. Click the link to have your say 👉 bit.ly/3ZAiPP8 #HEOR #healtheconomics #medicaleconomics

Looking ahead to 2026: Which #pharmacoeconomic topics will have the most impact? Share your expertise in this important discussion by completing our brief survey 👉 invt.io/1bxbq6unbf0 The results will be shared in an upcoming article in Taylor & Francis's health economics journals. #HEOR

🚨New Article🚨 Read our latest article titled "Use of external data to inform overall survival extrapolation in NICE technology appraisals for oncology drugs". Click to view the article in full 👉 bit.ly/452YBB1 #HEOR #Healtheconomics #Pharmacoeconomics #NICE #technologyappraisals

Excited to be attending ISPOR Annual in Montreal, reach out if you are attending too and would like to connect! #ispor2025 #ispor #heor #healtheconomics #outcomesresearch #healthpolicy #medicaleconomics #pharmacoeconomics

#Taylor&Francis commemorates 15 years of 𝗦𝗧𝗔𝗥 (𝗦𝗽𝗲𝗰𝗶𝗮𝗹 𝗧𝗲𝗿𝗺𝘀 𝗳𝗼𝗿 𝗔𝘂𝘁𝗵𝗼𝗿𝘀 𝗮𝗻𝗱 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵𝗲𝗿𝘀), an initiative aiding independent researchers without institutional affiliations. STAR grants access to cutting-edge research, bridging the gap for scholars worldwide. Learn more👉 bit.ly/4jx3Htl #publishing

📢 Exciting opportunity for researchers! 📢 Adding a #graphicalabstract to your article captures a greater audience and increases views. See an excellent example below, to read the article in full, click here 👇 bit.ly/42EeQ5O Want tips on how to make them? Get in touch 👇 [email protected]

🚨New article alert🚨 Our latest article looks at the associations between procedural volume, costs, and outcomes of septal reduction therapies for #obstructivehypertrophiccardiomyopathy in US hospitals. To read it in full, click the link 👉 bit.ly/42wHFkA #HEOR #healtheconomics #Cardiovascularhealth

🚨Journal news🚨 We are delighted to announce that Ishveen Chopra has joined our #EarlyCareerPanel. Ishveen is a seasoned leader in #HEOR, with a distinctive background spanning clinical, translational, and analytical research. We are excited to work with Ishveen to support her career.

🚨Available now!🚨 Read our latest article that analyzes the cost-effectiveness of various treatments for #haemophilia. Click the link for the full article 👉 bit.ly/3FN2GPb #costeffectiveness #HEOR #healtheconomics #pharmacoeconomics

Take a deep dive into what articles our readers viewed most last year and discover the Editor in Chief's recommended reads, which he selected based on their innovation and impact. Read the article in full here 👉 bit.ly/4c4oXnD #HEOR #Healtheconomics #pharmacoeconomics #medicaleconomics

Interested in how #plainlanguagesummaries can benefit your articles? Discover this and a lot more in our "𝐡𝐨𝐰 𝐭𝐨 𝐰𝐫𝐢𝐭𝐞 𝐚 𝐩𝐥𝐚𝐢𝐧 𝐥𝐚𝐧𝐠𝐮𝐚𝐠𝐞 𝐬𝐮𝐦𝐦𝐚𝐫𝐲" guide, available here 👉 bit.ly/3tUaWkX #PLS #laysummary #Taylor&Francis #healtheconomics #HEOR

🚨Available now🚨 Discover the cost-effectiveness of #semaglutide in people with #obesity and #cardiovasculardisease without #diabetes in this latest article in the Journal of Medical Economics Click the link for the full article 👉 bit.ly/4c7JlEn #costeffectiveness #HEOR #pharmacoeconomics

🚨Now online🚨 An incredibly insightful original research article published last week in the Journal of Medical Economics, to access it in full click here 👉 bit.ly/4iB3XHc Big thanks to the authors for publishing in JME.

Using #videoabstracts to discuss and summarise the findings of a paper is increasing in popularity for our authors. Below is a fantastic example, if you want to learn how to make them get in touch 👉 [email protected] To view the paper in full click here👉 bit.ly/4ihgK1O vimeo.com/1036790510

🚨Essential read🚨 The 𝙅𝙤𝙪𝙧𝙣𝙖𝙡 𝙤𝙛 𝙈𝙚𝙙𝙞𝙘𝙖𝙡 𝙀𝙘𝙤𝙣𝙤𝙢𝙞𝙘𝙨 𝙧𝙚𝙫𝙞𝙚𝙬 𝙤𝙛 𝟮𝟬𝟮𝟰, which consists of the journal's 𝐭𝐨𝐩 𝐟𝐢𝐯𝐞 𝐦𝐨𝐬𝐭 𝐯𝐢𝐞𝐰𝐞𝐝 𝐚𝐫𝐭𝐢𝐜𝐥𝐞𝐬 and Editor in Chief 𝐬𝐞𝐥𝐞𝐜𝐭𝐞𝐝 𝐚𝐫𝐭𝐢𝐜𝐥𝐞𝐬, which he picked for their innovation and impact. To read the article in full click the link 👉 bit.ly/4jEZRzd #HEOR #Healtheconomics

🚨 Now online🚨 Discover the budget impact of #resmetirom as a treatment for adults with non-cirrhotic non-alcoholic steatohepatitis with moderate-to-advanced liver fibrosis and estimated total costs for a hypothetical US private payer. Read the article here👉 bit.ly/4iWpfiq #liverdisease #HEOR

🎉Delighted to share our first plain language summary of publication on #transcatheteraorticvalvereplacement. Click the link to view the article in full 👉 bit.ly/3Fq36L2 Want to find out more about this article type, let me know: [email protected] #plsp #HEOR #healtheconomics #plainlanguage